GABAB receptor stimulation decreases amphetamine-induced behavior and neuropeptide gene expression in the striatum

Brain Research

Volumn 1004, Issue 1-2, 2004, Pages 18-28

  Zhou, Wenxia ^a   Mailloux, Adam W ^a   Jung, Bruce J ^a   Edmunds Jr , Hayward S ^a   McGinty, Jacqueline F ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Amphetamine; Baclofen; Dopamine; GABA receptors; Neuropeptide; Neurotransmitters, modulators, transporters, and receptors; Secretogranin II

Indexed keywords

4 AMINOBUTYRIC ACID B RECEPTOR; AMPHETAMINE; BACLOFEN; MESSENGER RNA; NEUROPEPTIDE; PREPRODYNORPHIN; PREPROENKEPHALIN; PREPROTACHYKININ; SECRETOGRANIN II;

ARTICLE; BEHAVIOR; CONTROLLED STUDY; CORPUS STRIATUM; DIALYSATE; DOPAMINE RELEASE; GENE EXPRESSION; HISTOCHEMISTRY; HUMAN; IN SITU HYBRIDIZATION; MOTOR ACTIVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REARING; REDUCTION; ANIMAL; BIOSYNTHESIS; COMPARATIVE STUDY; DRUG EFFECT; DRUG POTENTIATION; GENE EXPRESSION REGULATION; GENETICS; MALE; METABOLISM; PHYSIOLOGY; RAT; SPRAGUE DAWLEY RAT;

AMPHETAMINE; ANIMALS; BACLOFEN; CORPUS STRIATUM; GENE EXPRESSION REGULATION; MALE; MOTOR ACTIVITY; NEUROPEPTIDES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GABA-B; RNA, MESSENGER;

EID: 1642359894     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2003.11.077     Document Type: Article

References (40)

1. Agmo A., Belzung C., Giordano M. Interactions between dopamine and GABA in the control of ambulatory activity. J. Neural Transm. 103:1996;925-934.
2. Ahlenius S., Carlsson A., Engel J. Antagonism by baclophen of the D-amphetamine-induced disruption of a successive discrimination in the rat. J. Neural Transm. 36:1975;327-333.
3. Anderson J.J., Kuo S., Chase T.N., Engber T.M. Dopamine D1 receptor-stimulated release of acetylcholine in rat striatum is mediated indirectly by activation of striatal neurokinin1 receptors. J. Pharmacol. Exp. Ther. 269:1994;1144-1151.
4. Bowery N.G. GABAB receptor pharmacology. Annu. Rev. Pharmacol. Toxicol. 33:1993;109-147.
5. Brebner K., Phelan R., Roberts D.C.S. Effects of baclofen on cocaine self administration reinforced under FR1 and progressive ratio schedules. Psychopharmacol. 148:2000;314-321.
6. Brebner K., Childress A.R., Roberts D.C. A potential role for GABA(B) agonists in the treatment of psychostimulant addiction. Alcohol Alcohol. 37:2002;478-484.
7. Campbell U.C., Lac S.T., Carroll M.E. Effects of baclofen on maintenance and reinstatement of intravenous cocaine self-administration in rats. Psychopharmacology (Berlin). 143:1999;209-214.
8. Cole R.L., Konradi C., Douglass J., Hyman S.E. Neuronal adaptation to amphetamine and dopamine: molecular mechanisms of prodynorphin gene regulation in rat striatum. Neuron. 14:1995;813-823.
9. Cott J., Engel J. Suppression by GABAergic drugs of the locomotor stimulation induced by morphine, amphetamine, and apomorphine: evidence for both pre- and post-synaptic inhibition of catecholamine systems. J. Neural Transm. 40:1977;253-268.
10. Gerfen C.R., McGinty J.F., Young W.S. III Dopamine differentially regulates dynorphin, substance P, and enkephalin expression in striatal neurons: in situ hybridization histochemical analysis. J. Neurosci. 11:1991;1016-1031.
11. Gerkin R., Curry S.C., Vance M.V., Sankowski P.W., Meinhart R.D. First-order elimination kinetics following baclofen overdose. Ann. Emerg. Med. 15:1986;843-846.
12. Gonzalez-Nicolini V., McGinty J.F. NK-1 receptor blockade decreases amphetamine-induced behavior and neuropeptide mRNA expression in the striatum. Brain Res. 931:2002;41-49.
13. Gonzalez-Nicolini V., McGinty J.F. Gene expression profile from the striatum of amphetamine-treated rats: a cDNA array and in situ hybridization histochemical study. Brain Res. Gene Expr. Patterns. 1:2002;193-198.
14. Gonzalez-Nicolini V., Berglind W., Cole K.S., Keogh C.L., McGinty J.F. Local mu and delta opioid receptors regulate amphetamine-induced behavior and neuropeptide mRNA in the striatum. Neuroscience. 121:2003;387-398.
15. Gray A.M., Rawls S.M., Shippenberg T.S., McGinty J.F. The kappa-opioid agonist, U-69593, decreases acute amphetamine-evoked behaviors and calcium-dependent dialysate levels of dopamine and glutamate in the ventral striatum. J. Neurochem. 73:1999;1066-1074.
16. Guzman R.G., Kendrick K.M., Emson P.C. Effect of substance P on acetylcholine and dopamine release in the rat striatum: a microdialysis study. Brain Res. 622:1993;147-154.
17. Heijna M.H., Padt M., Hogenboom F., Portoghese P.S., Mulder A.H., Schoffelmeer A.N. Opioid receptor-mediated inhibition of dopamine and acetylcholine release from slices of rat nucleus accumbens, olfactory tubercle and frontal cortex. Eur. J. Pharmacol. 181:1990;267-278.
18. Humeniuk R.E., Ong J., Kerr D.I., White J.M. Characterization of GABAB ligands in vivo. Gen. Pharmacol. 26:1995;417-424.
19. Huttner W.B., Gerdes H.H., Rosa P. The granin (chromogranin/ secretogranin) family. Trends Biochem. Sci. 16:1991;27-30.
20. Jones E.A., Wang J.Q., McGinty J.F. Intrastriatal GABA(A) receptor blockade does not alter dopamine D(1)/D(2) receptor interactions in the intact rat striatum. Neuroscience. 102:2001;381-389.
21. Joyce E.M., Iversen S.D. Dissociable effects of 6-OHDA-induced lesions of neostriatum on anorexia, locomotor activity and stereotypy: the role of behavioural competition. Psychopharmacology (Berlin). 83:1984;363-366.
22. Joyce E.M., Stinus L., Iversen S.D. Effect of injections of 6-OHDA into either nucleus accumbens septi or frontal cortex on spontaneous and drug-induced activity. Neuropharmacology. 22:1983;1141-1145.
23. Kaupmann K., Huggel K., Heid J., Flor P.J., Bischoff S., Mickel S.J., McMaster G., Angst C., Bittiger H., Froestl W., Bettler B. Expression cloning of GABA(B) receptors uncovers similarity to metabotropic glutamate receptors. Nature. 386:1997;239-246.
24. Kelly P.H., Iversen S.D. Selective 6OHDA-induced destruction of mesolimbic dopamine neurons: abolition of psychostimulant-induced locomotor activity in rats. Eur. J. Pharmacol. 40:1976;45-56.
25. Kelly P.H., Seviour P.W., Iversen S.D. Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum. Brain Res. 94:1975;507-522.
26. Misgeld U., Bijak M., Jarolimek W. A physiological role for GABAB receptors and the effects of baclofen in the mammalian central nervous system. Prog. Neurobiol. 46:1995;423-462.
27. Nisenbaum E.S., Berger T.W., Grace A.A. Depression of glutamatergic and GABAergic synaptic responses in striatal spiny neurons by stimulation of presynaptic GABAB receptors. Synapse. 14:1993;221-242.
28. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. second edition:1996;Academic Press, Sydney, Australia.
29. Phillis B.D., Ong J., White J.M., Bonnielle C. Modification of D-amphetamine-induced responses by baclofen in rats. Psychopharmacology (Berlin). 153:2001;277-284.
30. Rawls S.M., McGinty J.F. Delta opioid receptors regulate calcium-dependent, amphetamine-evoked glutamate levels in the rat striatum: an in vivo microdialysis study. Brain Res. 861:2000;296-304.
31. Roberts D.C., Andrews M.M. Baclofen suppression of cocaine self-administration: demonstration using a discrete trials procedure. Psychopharmacology (Berlin). 131:1997;271-277.
32. Roberts D.C., Andrews M.M., Vickers G.J. Baclofen attenuates the reinforcing effects of cocaine in rats. Neuropsychopharmacology. 15:1996;417-423.
33. Scammell J.G., Sumners C., Reutter M.A., Valentine D.L., Jones L.C. Regulation of secretogranin II mRNA in rat neuronal cultures. Brain Res. Mol. Brain Res. 33:1995;326-332.
34. Shoaib M., Swanner L.S., Beyer C.E., Goldberg S.R., Schindler C.W. The GABAB agonist baclofen modifies cocaine self-administration in rats. Behav. Pharmacol. 9:1998;195-206.
35. Tzaferis J.A., McGinty J.F. Kappa opioid receptor stimulation decreases amphetamine-induced behavior and neuropeptide mRNA expression in the striatum. Brain Res. Mol. Brain Res. 93:2001;27-35.
36. Wang J.Q., McGinty J.F. Dose-dependent alteration in zif/268 and preprodynorphin mRNA expression induced by amphetamine or methamphetamine in rat forebrain. J. Pharmacol. Exp. Ther. 273:1995;909-917.
37. Wang J.Q., McGinty J.F. Alterations in striatal zif/268, preprodynorphin and preproenkephalin mRNA expression induced by repeated amphetamine administration in rats. Brain Res. 673:1995;262-274.
38. Wang J.Q., McGinty J.F. Intrastriatal injection of the metabotropic glutamate receptor antagonist MCPG attenuates acute amphetamine-stimulated neuropeptide mRNA expression in rat striatum. Neurosci. Lett. 218:1996;13-16.
39. Wang J.Q., McGinty J.F. Muscarinic receptors regulate striatal neuropeptide gene expression in normal and amphetamine-treated rats. Neuroscience. 75:1996;43-56.
40. You Z.B., Saria A., Fischer-Colbrie R., Terenius L., Goiny M., Herrera-Marschitz M. Effects of secretogranin II-derived peptides on the release of neurotransmitters monitored in the basal ganglia of the rat with in vivo microdialysis. Naunyn-Schmiedeberg's Arch. Pharmacol. 354:1996;717-724.